Clinical
HbA1c
Glycated hemoglobin — the standard 3-month marker of glycemic control.
Definition
HbA1c reflects average blood glucose over ~3 months. It is the primary endpoint in diabetes trials; GLP-1 agonists typically reduce HbA1c by 1-2.4 percentage points.
Related terms
Back to the full peptide glossary.